Skip to content

Other product segments

Casualty
7.4%+15.6%
Multiline
0.4%
Financial
0.2%
Property
0.1%-50.0%
Health
0%

Similar metrics at other companies

Arch Capital Group logo
ACGLSpecialty — Year Nine
0%
Horace Mann Educators logo
HMNSpecialty Health — Year Nine
0%
SiriusPoint logo
SPNTOther Specialties — Year 9
0.4%-0.1pp
White Mountains Insurance Group logo
WTMSpecialty — 9
1.2%-0.1pp
Arch Capital Group logo
ACGLMulti-line and other specialty — Year Nine
1.1%+0.3pp
Arch Capital Group logo
ACGLSpecialty — Year Ten
0.1%-0.2pp

Other financials

Income statement

See full
Revenue$189.7M-11.1%
Net income$35.8M+20.7%
EPS (diluted)$1.05+22.1%

Balance sheet

See full
Cash & equivalents$610.2M-5.1%
Total debt$4.7M-92.1%
Total equity$741.2M+11.2%
Total assets$2.3B+5.4%

Cash flow

See full
Operating cash flow$37.2M+259%

Valuation

See full
Market cap$533.32M+7.2%
Enterprise value-$72.18M-15.4%
P/E6.6×
P/S0.8×+0.1×

Profitability

See full
Net margin11.5%
FCF margin-46.7%

Returns & leverage

See full
Return on equity11.5%
Debt / equity-0.1×

Where this comes from

Reported directly by Greenlight Capital RE, Ltd. in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine.

The official record: Greenlight Capital RE, Ltd.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Greenlight Capital RE, Ltd.'s specialty — year 9.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Greenlight Capital RE, Ltd.'s specialty — year 9?
Greenlight Capital RE, Ltd. (GLRE) reported specialty — year 9 of 3.4% in Q4 2025.
What does specialty — year 9 mean?
Represents the gross premiums written or earned within the specialty reinsurance segment for the ninth year of the reporting period. This metric measures the scale of specialized insurance operations, providing insight into the company's strategic focus on niche markets. It is a critical component for evaluating revenue diversification and the effectiveness of underwriting specialty risks.